DrugPatentWatch Database Preview
Patent: 7,087,224
» See Plans and Pricing
Summary for Patent: 7,087,224
Title: | Method of treating anemia by administering IL-1ra |
Abstract: | The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist. |
Inventor(s): | Kay; Jonathan (Newton Centre, ME), McCabe; Dorothy (Moorpark, CA), Newmark; Richard (Newbury Park, CA), Coccia; Marco A. (Camarillo, CA) |
Assignee: | Amgen Inc. (Thousand Oaks, CA) |
Application Number: | 09/969,739 |
Patent Claims: | see list of patent claims |
Details for Patent 7,087,224
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 003 | 2001-11-14 | Start Trial | Amgen Inc. (Thousand Oaks, CA) | 2020-10-31 | RX | search | |
Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 002 | 2001-11-14 | Start Trial | Amgen Inc. (Thousand Oaks, CA) | 2020-10-31 | RX | search | |
Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 001 | 2001-11-14 | Start Trial | Amgen Inc. (Thousand Oaks, CA) | 2020-10-31 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 7,087,224
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 0236152 | Start Trial |
United States of America | 2002077294 | Start Trial |
United States of America | 2005106148 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |